Hip Fractures
Conditions
Brief summary
Our aim will be to compare the analgesic efficacy and safety of magnesium sulphate as an adjuvant to bupivacaine in pericapsular nerve group block in Hip joint surgeries. * Our primary outcome of the study: total amount of postoperative morphine consumption in the first 24h postoperative. * Our secondary outcome of the study: mean arterial blood pressure, heart rate, respiratory rate, adverse effects, block related complication, sedation score (by Ramsay sedation scale) and pain score (by Visual Analog Scale)
Interventions
DRUGPericapsular nerve group block using bupivicaine and magnesium sulphate
This technique involves the deposition of the local anesthetic in the fascial plane between the psoas muscle and the superior pubic ramus
Sponsors
Assiut University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* • Patients aged 18 years or more. * Patients with American society of anesthesiologists (ASA) classification class I or II * Patients weight range from 50 to 90 Kgs
Exclusion criteria
* • Patient refusal of peripheral nerve block * Patient with infection at the site of injection * Patient with coagulopathy * Patients with known allergy to used medications.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative pain management | 24 hours postoperatively | total amount of postoperative morphine consumption in the first 24 hours postoperatively. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Visual analog scale | 24 hours postoperatively | It's a scale from 0 to 10 where 0 means no pain and 10 means worst pain imaginable |
Countries
Egypt
Contacts
Primary ContactMustafa M Bekhet, MBBCH
Outcome results
None listed